Bayer, Janssen Duck Louisiana Blue Cross' Xarelto Claims

By Mike Curley ( July 9, 2021, 5:18 PM EDT) -- A Louisiana federal judge has thrown out claims by the state's Blue Cross and Blue Shield alleging it was tricked into paying out for subscriptions to blood thinner Xarelto after Bayer Pharma AG and Janssen Pharmaceuticals Inc. misrepresented its safety, saying the health insurer can't draw a line between any wrongdoing by drugmakers and any harm it suffered....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!